Medline Financial Ratios
NASDAQ: MDLNHealth CareMedical/Dental InstrumentsUSD
36.26+0.52 (+1.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medline ratio analysis
Medline earned a net margin of 4.1% in FY 2025. Gross margin was 26.4% compared with a median of 26.3% over the prior 2 years. Return on equity reached 10.8%, meaning Medline generated 0.11 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 1.17, and the current ratio was 4.29. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Medline financial ratios (annual)
| Ratio | FY 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Price / sales | 1.16 | — | — | — |
| Price / book | 3.06 | — | — | — |
| Gross margin | 26.4% | — | 27.3% | 25.3% |
| Operating margin | 7.8% | — | 8.4% | 5.4% |
| Net margin | 4.1% | — | 4.6% | 1.0% |
| Free cash flow margin | 4.6% | — | 5.5% | 6.1% |
| Return on equity (ROE) | 10.8% | — | — | — |
| Return on assets (ROA) | 3.0% | — | 3.2% | — |
| Debt / equity | 1.17 | — | — | — |
| Current ratio | 4.29 | — | 3.39 | — |
| Revenue growth | — | — | 9.8% | — |